Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF

Decreased Interstitial FOXP3+ Lymphocytes in Usual Interstitial Pneumonia with Discrepancy of CXCL12/CXCR4 Axis

(2017) Y. Shimizu et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Idiopathic pulmonary fibrosis: An update

(2015) Paolo Spagnolo et al.   ANNALS OF MEDICINE

Low ficolin-2 levels in common variable immunodeficiency patients with bronchiectasis

(2015) M.-L. Metzger et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Streptococcus pneumoniae triggers progression of pulmonary fibrosis through pneumolysin

(2015) S. Knippenberg et al.   THORAX

The Role of Bacteria in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis

(2014) Phillip L. Molyneaux et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The Role of Metalloproteinase ADAM17 in Regulating ICOS Ligand–Mediated Humoral Immune Responses

(2014) Joanna Marczynska et al.   JOURNAL OF IMMUNOLOGY

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

(2014) Talmadge E. King et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

(2014) Luca Richeldi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Increase in both angiogenic and angiostatic mediators in patients with idiopathic pulmonary fibrosis

(2014) D.M. Smadja et al.   PATHOLOGIE BIOLOGIE

Systems Level Analysis and Identification of Pathways and Networks Associated with Liver Fibrosis

(2014) Mohamed Diwan M. AbdulHameed et al.   PLoS One

Proteolysis mediated by cysteine cathepsins and legumain—recent advances and cell biological challenges

(2014) Klaudia Brix et al.   PROTOPLASMA

Potential role of the lectin pathway of complement in the pathogenesis and disease manifestations of systemic sclerosis: a case-control and cohort study

(2014) Michael Osthoff et al.   ARTHRITIS RESEARCH & THERAPY

Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study

(2014) MeiLan K Han et al.   Lancet Respiratory Medicine

Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic Agents

(2014) John C Rohloff et al.   Molecular Therapy-Nucleic Acids

An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

(2013) William D. Travis et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis

(2013) Tasha E Fingerlin et al.   NATURE GENETICS

Human cystatin C: A new biomarker of idiopathic pulmonary fibrosis?

(2013) Mariana Kasabova et al.   Proteomics Clinical Applications

Outcomes in idiopathic pulmonary fibrosis: A meta-analysis from placebo controlled trials

(2013) C.P. Atkins et al.   RESPIRATORY MEDICINE

Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis

(2013) J. D. Herazo-Maya et al.   Science Translational Medicine

Toward a Refined Definition of Monocyte Subsets

(2013) Loems Ziegler-Heitbrock et al.   Frontiers in Immunology

Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis

(2012) Payal K. Naik et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Semaphorin 7a+Regulatory T Cells Are Associated with Progressive Idiopathic Pulmonary Fibrosis and Are Implicated in Transforming Growth Factor-β1–induced Pulmonary Fibrosis

(2012) Ronald A. Reilkoff et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Imbalance of circulating endothelial cells and progenitors in idiopathic pulmonary fibrosis

(2012) David M. Smadja et al.   ANGIOGENESIS

Angiogenesis in Pulmonary Fibrosis

(2012) Chandru Hanumegowda et al.   CHEST

Biomarkers in idiopathic pulmonary fibrosis

(2012) Yingze Zhang et al.   CURRENT OPINION IN PULMONARY MEDICINE

Human L-Ficolin (Ficolin-2) and Its Clinical Significance

(2012) David C. Kilpatrick et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Mice Deficient in Ficolin, a Lectin Complement Pathway Recognition Molecule, Are Susceptible to Streptococcus pneumoniae Infection

(2012) Y. Endo et al.   JOURNAL OF IMMUNOLOGY

PRSS3/Mesotrypsin Is a Therapeutic Target for Metastatic Prostate Cancer

(2012) A. Hockla et al.   MOLECULAR CANCER RESEARCH

Prednisone, Azathioprine, andN-Acetylcysteine for Pulmonary Fibrosis

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Cathepsin S Deficiency Results in Abnormal Accumulation of Autophagosomes in Macrophages and Enhances Ang II–Induced Cardiac Inflammation

(2012) Lili Pan et al.   PLoS One

The Lectin Pathway of Complement Activation Is a Critical Component of the Innate Immune Response to Pneumococcal Infection

(2012) Youssif M. Ali et al.   PLoS Pathogens

Targeting cathepsin S induces tumor cell autophagy via the EGFR–ERK signaling pathway

(2011) Kuo-Li Chen et al.   CANCER LETTERS

Metalloproteinases in idiopathic pulmonary fibrosis

(2011) R. C. A. Dancer et al.   EUROPEAN RESPIRATORY JOURNAL

Inducible costimulator ligand regulates bleomycin-induced lung and skin fibrosis in a mouse model independently of the inducible costimulator/inducible costimulator ligand pathway

(2010) Chihiro Tanaka et al.   ARTHRITIS AND RHEUMATISM

Expression Analysis of Angiogenic Growth Factors and Biological Axis CXCL12/CXCR4 Axis in Idiopathic Pulmonary Fibrosis

(2010) Katerina M. Antoniou et al.   CONNECTIVE TISSUE RESEARCH

PRSS3 promotes tumour growth and metastasis of human pancreatic cancer

(2010) G. Jiang et al.   GUT

Significance of Serum Vascular Endothelial Growth Factor Level in Patients with Idiopathic Pulmonary Fibrosis

(2010) Masaru Ando et al.   LUNG

CD28 Down-Regulation on Circulating CD4 T-Cells Is Associated with Poor Prognoses of Patients with Idiopathic Pulmonary Fibrosis

(2010) Syed R. Gilani et al.   PLoS One

Antibody Targeting of Cathepsin S Inhibits Angiogenesis and Synergistically Enhances Anti-VEGF

(2010) Claire Ward et al.   PLoS One

Viral infection and aging as cofactors for the development of pulmonary fibrosis

(2010) Payal K Naik et al.   Expert Review of Respiratory Medicine

Global Impairment of CD4+CD25+FOXP3+Regulatory T Cells in Idiopathic Pulmonary Fibrosis

(2009) Ioannis Kotsianidis et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Serum Inter–α-Trypsin Inhibitor and Matrix Hyaluronan Promote Angiogenesis in Fibrotic Lung Injury

(2008) Stavros Garantziotis et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Vascular Endothelial Growth Factor Mediated Decrease in Plasma Soluble Vascular Endothelial Growth Factor Receptor-2 Levels as a Surrogate Biomarker for Tumor Growth

(2008) J. M.L. Ebos et al.   CANCER RESEARCH

Stable bronchiectasis is associated with low serum L-ficolin concentrations

(2008) David Chalmers Kilpatrick et al.   Clinical Respiratory Journal

Approaching the degradome in idiopathic pulmonary fibrosis☆

(2008) A PARDO et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY